However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...

Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...

Amid the brighter spotlights being directed at data use in clinical trials, synthetic control arms represent a unique approach. Synthetic control arms use statistical methods to create a virtual ...

Malaria control and elimination is threatened by the spread of insecticide resistance and behavioral adaptation of vectors. Whether mass administration of ivermectin, a broad-spectrum antiparasitic ...